MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells.

MLA

Pratelli, Giovanni, et al. “MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells.” International Journal of Molecular Sciences, vol. 24, no. 13, July 2023, p. 11149. EBSCOhost, https://doi.org/10.3390/ijms241311149.

APA

Pratelli, G., Carlisi, D., Di Liberto, D., Notaro, A., Giuliano, M., D’Anneo, A., Lauricella, M., Emanuele, S., Calvaruso, G., & De Blasio, A. (2023). MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells. International Journal of Molecular Sciences, 24(13), 11149. https://doi.org/10.3390/ijms241311149

Chicago

Pratelli, Giovanni, Daniela Carlisi, Diana Di Liberto, Antonietta Notaro, Michela Giuliano, Antonella D’Anneo, Marianna Lauricella, Sonia Emanuele, Giuseppe Calvaruso, and Anna De Blasio. 2023. “MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells.” International Journal of Molecular Sciences 24 (13): 11149. doi:10.3390/ijms241311149.